ENTITY

Hansoh Pharmaceutical Group (3692 HK)

185

Analysis

Health Care • China

Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.

more

Refresh

Exchange Announcement • 18 Dec 2024 19:07

Inside Information - License Agreement With Msd

Exchange Announcement • 17 Dec 2024 20:43

Voluntary Announcement - The Clinical Trial Approval For Hs-20110 For Injection Issued By The National Medical Products Administration

Exchange Announcement • 16 Dec 2024 19:18

Voluntary Announcement - B7-H3-Targeted Antibody-Drug Conjugate Hs-20093 Received Ema Priority Medicines Designation

Exchange Announcement • 28 Nov 2024 20:37

Voluntary Announcement - Four Innovative Drugs Renewed In The 2024 National Reimbursement Drug List

Exchange Announcement • 27 Nov 2024 18:32

Voluntary Announcement - The Fifth New Drug Application Of Ameile (Aumolertinib Mesilate Tablets) Was Accepted By The National Medical Products Administration

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x